Meningococcal Vaccine 0.5 mL Suppliers & Bulk Manufacturers
Available Forms: Vial or pre-filled syringe (injectable), Conjugate vaccines
Available Strengths: 0.5 mL
Reference Brands: Menactra, Menveo(US), NmVac4-DT (India)
Category: Vaccines
Meningococcal vaccines stimulate immunity by introducing purified polysaccharide or protein antigens from Neisseria meningitidis bacteria. They produce protective antibodies, preventing meningococcal meningitis and septicemia. Benefits include long-lasting immunity, outbreak control, and protection for high-risk populations, supporting global efforts to reduce meningococcal disease morbidity and mortality.
Product Description:
Meningococcal vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves extensive clinical data, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective meningococcal vaccines vital for disease prevention, outbreak control, and protection of high-risk populations globally.
Meningococcal Vaccine — third party manufacturing & bulk supply
Meningococcal Vaccine 0.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Meningococcal Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Meningococcal Vaccine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Meningococcal Vaccine is used to prevent meningococcal disease caused by the bacterium Neisseria meningitidis. This serious infection can lead to meningitis (infection of the lining of the brain and spinal cord) and bloodstream infections. The vaccine helps protect individuals, especially children, adolescents, and travelers to high-risk regions.
Meningococcal vaccines are made from purified components of the Neisseria meningitidis bacteria. Depending on the type, they may contain polysaccharides from the bacterial capsule or conjugated polysaccharides linked to a carrier protein to enhance immune response.
Common trade names include Menactra, Menveo, Nimenrix, Bexsero, and Trumenba.
Meningococcal vaccines are manufactured by several pharmaceutical companies including Sanofi Pasteur, GlaxoSmithKline (GSK), Pfizer, and Serum Institute of India.
The generic name is meningococcal vaccine or meningococcal conjugate vaccine depending on the formulation.
Brand names include Menactra, Menveo, Nimenrix, Bexsero, and Trumenba.
Meningococcal vaccines are manufactured in multiple countries including the United States, United Kingdom, Italy, Belgium, and India depending on the manufacturer.
Related Products
Respiratory Syncytial Virus Mrna Vaccine
Strength:
0.5 mL
Form: injection (prefilled syringe)
Reference Brands: mRESVIA (USA/EU)
View Details
Inactivated Vaccines
Strength:
Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details
Viral Vector Vaccines
Strength:
0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details
Mrna-Based Vaccines
Strength:
30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
